Competition between domestic and foreign pharmaceutical machinery companies has intensified, and import substitution may become an inevitable trend

With the continuous deepening of medical reform, a series of new changes are taking place in the competitive landscape of the medical industry
.
For example, the process of domestically replacing imports is being accelerated by the policy of preferential procurement of domestically-made equipment
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) The industry believes that with the gradual increase in the proportion of domestic equipment winning bids in various places, in the future, there will be a situation of full competition between domestic equipment and imported equipment in the pharmaceutical equipment market
.
It is worth mentioning that in addition to the continued acceleration of the substitution of pharmaceutical equipment and equipment, the industry expects that the domestic pharmaceutical equipment industry in the upstream of the pharmaceutical industry may also continue to accelerate the substitution of imports
.
It is understood that for a long time before, China's domestic pharmaceutical equipment market was mainly concentrated in the low-end field, with low-level repetitive production and low-price competition as the main focus, while the high-end market basically relied on imports
.
However, in recent years, with the wave of innovation sweeping across all walks of life, domestic pharmaceutical companies are currently accelerating the enhancement of added value and quality of their products, and continuously upgrading to overall solutions under the continuous increase of R&D investment
.
Affected by this, the proportion of high-end products of domestic pharmaceutical equipment companies has also begun to increase
.
For example, when Chutian Technology accepted an institutional survey on July 19 this year, it stated that the company had been deploying import substitution in the high-end market of vaccine products three years ago.
The product performance and quality have been able to meet the needs of high-end customers.
The supply chain of the high-end vaccine industry has been established, and it will compete with imported equipment on the same platform
.
At present, the company is highly optimistic about the market demand growth brought about by the related stock market of import substitution in the future
.
The industry predicts that with the continuous improvement of local enterprises' quality and technology, and the continuous increase of overseas market demand, the delivery capabilities of domestic manufacturers will be further reflected, and domestic substitution will surely be accelerated
.
However, it should be noted that although in the general environment, the domestic pharmaceutical equipment industry is ushering in rapid development
.
But in fact, there are still some bottlenecks in domestic substitution of imports.

.
Among them, there are two main aspects.
One is the technical level.
Some core components and key technical fields of domestic enterprises have not broken through the existing bottlenecks.
In some high-end fields, some technical performance and product quality still lag behind imported products
.
On the other hand, there is the issue of user recognition.
At present, under the background that many domestic pharmaceutical companies still prefer imported equipment, local companies still have a long way to go
.
However, analysts also pointed out that in recent years, as domestic pharmaceutical equipment technology has gradually matured, especially after domestic manufacturers have introduced foreign technology, the market space open to domestic pharmaceutical equipment has actually become larger and larger
.
Data shows that the current domestic pharmaceutical equipment market has a complete range of products, high quality and low price.
While meeting the domestic market demand, overseas market demand is growing, and the average annual export value of exports has reached an average growth rate of 23%
.
In this context, the industry predicts that in the future, as the concentration of the domestic pharmaceutical equipment industry continues to increase, the training of professional talents is continuously strengthened, and the continuous innovation of pharmaceutical equipment companies will better compete with foreign products.
And continue to promote the development of the domestic pharmaceutical equipment industry in a higher quality direction
.